As I noted in a recent tweetorial, Raymond Pearl reported a lower frequency of cancer in those with evidence of tuberculosis.

This finding led Pearl and others to treat patients with tuberculin.

Unfortunately, Pearl's original study methods suffered from bias.
More specifically, Pearl's study sample contained an overrepresentation of exposed controls (i.e., control subjects who had died from tuberculosis).

This led to an incorrect conclusion that tuberculosis is associated with decreased rates of cancer.
Pearl published a "retraction" in Science.

While arguing that "any serious student of the matter" would agree that TB and cancer are rarely found together in the same person, he admits that concluding a mechanistic connection "may have been erroneous".

pubmed.ncbi.nlm.nih.gov/17777405/
This story was highlighted well in a great review by Kim Sutton-Tyrrell entitled "Assessing Bias in Case-Control Studies".

@LFGarabedian and @rbganatra - you'll like this one

pubmed.ncbi.nlm.nih.gov/1853415/
Unfortunately, most papers that reference Pearl's original study do not mention its flaws.

Once something with profound implications is "out there" what follows - even a retraction - is often lost in its wake.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Tony Breu

Tony Breu Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @tony_breu

14 Aug
1/16
Why do we use a vaccine (BCG) to treat an unrelated malignancy (bladder cancer)?

Can infections really prevent/treat cancer?

Let's find out.
2/
This story begins in 1813 when Arsène-Hippolyte Vautier reported that patients suffering from gas gangrene experienced a decrease in the size of their malignant tumors.

An explanation (or even the causative bacterium!) wasn't immediately apparent.

pubmed.ncbi.nlm.nih.gov/28202530/
Read 19 tweets
26 Jul
1/15
Why does clostridium difficile infection (CDI) cause marked leukocytosis?

Many of you have likely seen a new WBC >20k and wondered "could this patient have CDI?"

Are you right to wonder? If so, why?
2/
To start, is there a connection?

One of the earliest studies examined patients with WBC >30k. They reported the following rates of CDI:

🔹20% of all cases (excluding those with heme malignancy)
🔹34% of patients with an infectious etiology

pubmed.ncbi.nlm.nih.gov/12032893/
3/
In another study included 60 patients with unexplained leukocytosis (WBC >15k) and found:

⚡️58% had CDI⚡️

And: leukocytosis preceded recorded symptoms of colitis in half of the patients.

pubmed.ncbi.nlm.nih.gov/14599633/
Read 15 tweets
11 May
Great list Avi!

I'll add some relevant links for a few of these.
💻K/Mg repletion often unnecessary

Here is a tweetorial on potassium repletion/replacement.

💻Wilson disease evaluation in acute liver failure often not needed

@ebtapper and @ShaniHerzig wrote a great article in the @JHospMedicine Things We Do For No Reason Series on nondirected testing for inpatients with severe liver injury.

journalofhospitalmedicine.com/jhospmed/artic…
Read 6 tweets
17 Apr
1/6
Does doxycycline protect against clostridium difficile infection (CDI)?

If so, why?

These questions came up on rounds yesterday. Here are some potential answers.
2/
One study found an adjusted hazard ratio of 0.73 for CDI with the use of doxycycline.

A separate meta-analysis supported this finding with an odds ratio of 0.62 with all tetracyclines. The forest plot is attached.

pubmed.ncbi.nlm.nih.gov/22563022/
pubmed.ncbi.nlm.nih.gov/29401273/
3/
One potential explanation is that tetracyclines have in vitro activity against C. difficile.

This was demonstrated in a study reporting that 84% of C. difficile isolates had an MIC of ≤0.25 mg/L to tetracycline.

pubmed.ncbi.nlm.nih.gov/19732094/
Read 6 tweets
2 Apr
1/13
Why doesn't hemolysis cause acute kidney injury as easily as rhabdomyolysis?

I see a lot of hemolysis and can't think of a case of AKI that resulted.

Rhabdo? I immediately worry about AKI.

If heme is the toxic molecule, shouldn't both conditions be equally nephrotoxic?
2/
🔑Heme is contained in both hemoglobin and myoglobin and is the toxic molecule in BOTH hemolysis and rhabdomyolysis.

The mechanism of heme toxicity won't be covered in this thread. Instead, we'll stick with why rhabdo causes more AKI.

pubmed.ncbi.nlm.nih.gov/31018590/
3/
Before moving on, it is important to note that hemolysis CAN cause AKI.

Historically, massive hemolysis from ABO mismatch was a major cause. Now the causes are more varied.

pubmed.ncbi.nlm.nih.gov/31668630/
Read 13 tweets
31 Mar
1/9
Great question!

From what I gather, the exact explanation for the low alkaline phosphatase in Wilson's disease remains unexplained.
2/
The first description of the association between low AP and Wilson's came in a 1986 paper by Shaver, Bhatt, and Combes.

pubmed.ncbi.nlm.nih.gov/3758940/
3/
They describe patients with acute hemolytic anemia in the setting of Wilson's disease who are noted to have low AP.

They wonder whether the acute increase in serum copper may compete with zinc for incorporation into AP.

pubmed.ncbi.nlm.nih.gov/3758940/
Read 9 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(